aid: helix-nano
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/helix-nano.png
name: Helix Nano
description: Helix Nano (HelixNano) is a Boston-based biotechnology company developing
  new ways to manipulate messenger RNA (mRNA) — the molecule that carries instructions
  from genes to the cell's protein-making machinery. Backed by DCVC since 2017, the
  company has developed techniques to improve the effectiveness and specificity of
  mRNA vaccines, including a next-generation COVID-19 vaccine engineered to resist
  viral mutation. HelixNano is now pursuing a broader vision of self-designing, adaptive
  therapeutics — drugs that could improve with every patient and, ideally, require
  only a single dose. The company operates out of 5 Channel Center Street in Boston,
  Massachusetts, and remains at an early, largely stealth stage with no public developer
  program or API surface at this time.
url: https://raw.githubusercontent.com/api-evangelist/helix-nano/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- mRNA
- Vaccines
- Therapeutics
- Life Sciences
- Drug Discovery
apis: []
common:
- type: DomainSecurity
  url: security/helix-nano-domain-security.yml
- type: Website
  url: https://www.helixnano.com
- type: Careers
  url: https://www.helixnano.com/careers
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence